Docetaxel in Treating Patients With Persistent or Recurrent Cervical Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase II trial to study the effectiveness of docetaxel in treating patients who have
persistent or recurrent cervical cancer. Drugs used in chemotherapy use different ways to
stop tumor cells from dividing so they stop growing or die.